The US Food and Drug Administration has announced that the children of mothers who took medications including or related to valproate sodium during pregnancy show decreased IQ scores, and that these drugs are now contraindicated for pregnant women.
Women who have migraine with aura, especially those who take combined hormonal contraceptives (CHCs) have an increased risk for cardiovascular or thrombotic events.
According to some estimates, menstrual migraine effect about 60% to 70% of women. Since hormone levels might impact these migraines, Dr Vincent De Leo from the department of obstetrics and gynecology at the University of Siena in Italy, and colleagues sought to examine the impact of two different oral contraception regimens on the migraines.
Evidence shows that combined oral contraceptives are contraindicative in women who have migraines with auras (MA) due to increased risk of ischemic stroke. So what can these women do?